{"id":2024,"date":"2017-12-31T00:00:02","date_gmt":"2017-12-30T17:00:02","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2024"},"modified":"2022-03-30T10:06:12","modified_gmt":"2022-03-30T03:06:12","slug":"a-phase-iii-randomized-double-blind-study-to-evaluate-the-safety-and-efficacy-of-gf-9350-boosted-atazanavir-versus-ritonavir-boosted-atazanavir-each-administered-with-emtricitabine-tenofovir-disopro","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2024\/","title":{"rendered":"A phase 3, randomized, double-blind study to evaluate the safety and efficacy of GF-9350-boosted Atazanavir versus Ritonavir-boosted Atazanavir each administered with Emtricitabine\/Tenofovir disoproxil fumarate in HIV-1 infected, antiretroviral treatment-na\u00efve adults"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">This is a multicenter phase III, randomized, double-blind, active-controlled study to evaluate the safety and efficacy of a regimen containing GS-9350-boosted atazanavir (ATV\/GS-9350) versus ritonavir-boosted atazanavir (ATV\/r) each administered with emtricitabine\/tenofovir disoproxil fumarate (Truvada\u00ae, FTC\/TDF) in HIV-1 infected, antiretroviral treatment-na\u00efve adult subjects.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis is a multicenter phase 3, randomized, double-blind, active-controlled study to evaluate the safety and efficacy of a regimen containing GS-9350-boosted atazanavir (ATV\/GS-9350) versus ritonavir-boosted atazanavir (ATV\/r) each administered with emtricitabine\/tenofovir disoproxil fumarate (Truvada\u00ae, FTC\/TDF) in HIV-1 infected, antiretroviral treatment-na\u00efve adult subjects.\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2024","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2024"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2024\/revisions"}],"predecessor-version":[{"id":3342,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2024\/revisions\/3342"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}